ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript May 7, 2025
ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.16.
Operator: Good afternoon and welcome to the ADMA Biologics First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 7, 2025. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being...
